Royal Bank of Canada
OGEN icon

Royal Bank of Canada’s Oragenics OGEN Stock Holding History

Royal Bank of Canada’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
1
– – ﹤0.01% 7511
2025
Q4 		$0 Hold
1
– – ﹤0.01% 7483
2025
Q3 		$0 Hold
1
– – ﹤0.01% 7392
2025
Q2 		$0 Buy
+1
New +$5 ﹤0.01% 7244
2025
Q1 		– Hold
0
– – – 7114
2024
Q4 		– Hold
0
– – – 7140
2024
Q3 		– Hold
0
– – – 7254
2024
Q2 		– Hold
0
– – – 7394
2024
Q1 		– Hold
0
– – – 7420
2023
Q4 		– Hold
0
– – – 7443
2023
Q3 		– Hold
0
– – – 7421
2023
Q2 		– Hold
0
– – – 7533
2023
Q1 		– Hold
0
– – – 7349
2022
Q4 		– Hold
0
– – – 7572
2020
Q1 		– Sell
-1
Closed -$1K – 6922
2019
Q4 		$1K Hold
1
– – ﹤0.01% 6674
2019
Q3 		$1K Buy
+1
New +$835 ﹤0.01% 6490
2018
Q2 		– Hold
0
– – – 6695
2018
Q1 		– Hold
0
– – – 6664
2017
Q4 		– Hold
0
– – – 6778
2017
Q3 		– Hold
0
– – – 6893
2015
Q3 		– Hold
0
– – – 6742
2015
Q2 		– Hold
0
– – – 6674
2015
Q1 		– Hold
0
– – – 6336
2014
Q4 		– Hold
0
– – – 6261
2014
Q3 		– Hold
0
– – – 5874
2014
Q2 		– Hold
0
– – – 5824
2014
Q1 		– Hold
0
– – – 5808
2013
Q4 		– Hold
0
– – – 5835
2013
Q3 		– Hold
0
– – – 5861
2013
Q2 		– Hold
0
– – – 5624

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Royal Bank of Canada's OGEN Position: Q1 2026 in Review

Royal Bank of Canada held its Oragenics (OGEN) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7511.

Royal Bank of Canada first reported a position in OGEN in Q3 2019 and has held it in 6 quarters since. The position peaked at $1K in Q4 2019. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Royal Bank of Canada held 1 share of Oragenics worth $0 as of Q1 2026.
  • Royal Bank of Canada left its Oragenics share count unchanged in Q1 2026.
  • Oragenics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7511 holding.
  • Royal Bank of Canada first reported a position in Oragenics in Q3 2019 and has held it in 6 quarters since.
  • Royal Bank of Canada's Oragenics position peaked at $1K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.